# Aeterna Zentaris Inc. (AEZS)

Source: https://www.quantisnow.com/company/AEZS
Generated: 2026-11-15T22:37:58.265Z

- Ticker: AEZS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: zentaris.com

## About

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, a peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen name. Aeterna Zentaris Inc. has a license agreement with Julius-Maximilians-University Wuerzburg for the development of an oral prophylactic bacterial vaccine against COVID-19 disease; development, manufacture, and commercialization of targeted immunosuppressive therapeutic proteins for the treatment of neuromyelitis optica spectrum disorder. It also has a license agreement with Consilient Health Ltd. and Novo Nordisk Biopharm Limited for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

## Latest AEZS news and filings

- 2024-08-13 12:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5656152)
- 2024-08-13 12:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5656149)
- 2024-08-06 22:22 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5645977)
- 2024-08-06 22:00 UTC [Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.](https://www.quantisnow.com/insight/aeterna-zentaris-inc-announces-name-change-to-cosciens-biopharma-inc-5645798)
- 2024-07-16 22:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5611646)
- 2024-07-16 20:05 UTC [Leadership Update] [Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders](https://www.quantisnow.com/insight/aeterna-zentaris-announces-results-of-virtual-2024-meeting-of-shareholders-5610797)
- 2024-07-01 21:46 UTC [Leadership Update] [Mannatech Announces Appointment of James Clavijo as Chief Financial Officer](https://www.quantisnow.com/insight/mannatech-announces-appointment-of-james-clavijo-as-chief-financial-officer-5587577)
- 2024-06-25 19:36 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5576247)
- 2024-06-13 13:20 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5555540)
- 2024-06-13 13:19 UTC [Market Chatter] [Aeterna Zentaris Completes Phase 3 DETECT-Trial For Macimorelin In Diagnosing Childhood Onset Growth Hormone Deficiency; Top-Line Data And Full Study Results Expected In Q3 2024](https://www.quantisnow.com/insight/aeterna-zentaris-completes-phase-3-detect-trial-for-macimorelin-in-diagnosing-5555534)
- 2024-06-13 13:10 UTC [Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency](https://www.quantisnow.com/insight/aeterna-zentaris-announces-last-patient-last-visit-in-pivotal-detect-trial-5555493)
- 2024-06-10 17:31 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5548011)
- 2024-06-06 17:46 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-aeterna-zentaris-inc-5542079)
- 2024-06-05 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-aeterna-zentaris-inc-5537761)
- 2024-06-05 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-aeterna-zentaris-inc-5537758)
- 2024-06-05 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-aeterna-zentaris-inc-5537736)
- 2024-06-03 13:15 UTC [Aeterna Zentaris and Ceapro Complete Merger Transaction](https://www.quantisnow.com/insight/aeterna-zentaris-and-ceapro-complete-merger-transaction-5531679)
- 2024-05-31 01:56 UTC [SEC Form POS AM filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-aeterna-zentaris-inc-5527706)
- 2024-05-31 01:56 UTC [SEC Form POS AM filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-aeterna-zentaris-inc-5527701)
- 2024-05-31 01:58 UTC [SEC Form S-8] [SEC Form S-8 filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-aeterna-zentaris-inc-5527695)
- 2024-05-31 01:55 UTC [SEC Form POS AM filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-aeterna-zentaris-inc-5527671)
- 2024-05-30 01:31 UTC [SEC Form 6-K] [SEC Form 6-K/A filed by Aeterna Zentaris Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-6-ka-filed-by-aeterna-zentaris-inc-amendment-5524358)
- 2024-05-29 22:35 UTC [Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date](https://www.quantisnow.com/insight/aeterna-zentaris-provides-update-on-timing-for-annual-meeting-of-5524058)
- 2024-05-17 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5499001)
- 2024-05-17 12:00 UTC [SEC Form FWP] [SEC Form FWP filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-fwp-filed-by-aeterna-zentaris-inc-5498996)
- 2024-05-17 12:00 UTC [Aeterna Zentaris Announces Details Regarding Transaction with Ceapro](https://www.quantisnow.com/insight/aeterna-zentaris-announces-details-regarding-transaction-with-ceapro-5498954)
- 2024-05-17 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-aeterna-zentaris-inc-5498675)
- 2024-05-15 23:02 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5495060)
- 2024-05-14 22:08 UTC [Market Chatter] [AEterna Zentaris Q1 2024 GAAP EPS $(4.74) Vs. $(3.51) Last Year](https://www.quantisnow.com/insight/aeterna-zentaris-q1-2024-gaap-eps-474-vs-351-last-5490470)
- 2024-05-14 22:00 UTC [Aeterna Zentaris Reports First Quarter 2024 Financial Results](https://www.quantisnow.com/insight/aeterna-zentaris-reports-first-quarter-2024-financial-results-5490453)
- 2024-05-09 00:21 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5474345)
- 2024-05-03 12:55 UTC [Market Chatter] [Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times](https://www.quantisnow.com/insight/trading-halt-halt-status-updated-at-85500-am-et-quotation-5457109)
- 2024-05-01 20:51 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5450324)
- 2024-05-01 11:58 UTC [Market Chatter] [Aeterna Zentaris Announced That It Has Filed Articles Of Amendment To Effect The Previously Announced Share Consolidation (or Reverse Stock Split) Of Its Issued And Outstanding Common Shares](https://www.quantisnow.com/insight/aeterna-zentaris-announced-that-it-has-filed-articles-of-amendment-5447473)
- 2024-05-01 11:55 UTC [Aeterna Zentaris Announces Effective Date of Share Consolidation](https://www.quantisnow.com/insight/aeterna-zentaris-announces-effective-date-of-share-consolidation-5447462)
- 2024-03-28 14:28 UTC [SEC Form 6-K] [SEC Form 6-K filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-aeterna-zentaris-inc-5374677)
- 2024-03-28 11:55 UTC [Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris](https://www.quantisnow.com/insight/ceapro-receives-final-court-approval-for-merger-with-aeterna-zentaris-5374013)
- 2024-03-27 13:10 UTC [Market Insight] [AEterna Zentaris: Q4 Earnings Insights](https://www.quantisnow.com/insight/aeterna-zentaris-q4-earnings-insights-5371333)
- 2024-03-27 12:10 UTC [Market Chatter] [AEterna Zentaris Q4 2023 GAAP EPS $(1.16) Misses $(0.97) Estimate, Sales $100.000K Down From $2.485M YoY](https://www.quantisnow.com/insight/aeterna-zentaris-q4-2023-gaap-eps-116-misses-097-estimate-5371019)
- 2024-03-27 12:05 UTC [SEC Form 20-F filed by Aeterna Zentaris Inc.](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-aeterna-zentaris-inc-5371006)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AEZS
- Earnings history: https://www.quantisnow.com/earnings/AEZS
- Dividend history: https://www.quantisnow.com/dividends/AEZS
- Insider transactions: https://www.quantisnow.com/insiders/AEZS
- Options chain: https://www.quantisnow.com/options/AEZS
- SEC 8-K filings only: https://www.quantisnow.com/company/AEZS/8-k
- RSS and alerts for AEZS: https://www.quantisnow.com/docs/rss-feeds.md